These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 11036475)
21. Tamoxifen in early breast cancer. Bryce CJ Lancet; 1998 Aug; 352(9125):403. PubMed ID: 9717952 [No Abstract] [Full Text] [Related]
22. Navigating the Challenges of Endocrine Treatments in Premenopausal Women with ER-Positive Early Breast Cancer. Colleoni M; Munzone E Drugs; 2015 Aug; 75(12):1311-21. PubMed ID: 26177891 [TBL] [Abstract][Full Text] [Related]
23. Response to aminoglutethimide after failure of tamoxifen therapy in breast cancer. Sutherland CM; Muchmore JH; Carter RD South Med J; 1985 Aug; 78(8):987-9. PubMed ID: 4023793 [TBL] [Abstract][Full Text] [Related]
24. [Factors related to adjuvant ovarian function suppression in premenopausal breast cancer patients]. Liang Y; Chen XS; Wu JY; Huang O; Zong Y; Nie LJ; Fang Q; He JR; Zhu L; Chen WG; Li YF; Shen KW Zhonghua Zhong Liu Za Zhi; 2016 May; 38(5):357-62. PubMed ID: 27188608 [TBL] [Abstract][Full Text] [Related]
25. Tamoxifen's impact on the management of breast cancer: patient perspectives. Reichman BS Oncology (Williston Park); 1997 Feb; 11(2 Suppl 1):55-8. PubMed ID: 9065929 [TBL] [Abstract][Full Text] [Related]
26. Tamoxifen in early breast cancer. Benson JR Lancet; 1998 Aug; 352(9125):404-5. PubMed ID: 9717955 [No Abstract] [Full Text] [Related]
28. Tamoxifen in early breast cancer. Saibara T; Ogawa Y; Onishi S Lancet; 1998 Aug; 352(9125):404. PubMed ID: 9717954 [No Abstract] [Full Text] [Related]
29. Design of an ideal hormone replacement therapy for women. Tonetti DA; Jordan VC Mol Carcinog; 1996 Nov; 17(3):108-11. PubMed ID: 8944069 [No Abstract] [Full Text] [Related]
30. [Recent progress of endocrine therapy in breast cancer]. Nomura Y Gan To Kagaku Ryoho; 1992 Jun; 19(6):783-9. PubMed ID: 1605654 [TBL] [Abstract][Full Text] [Related]
31. Raloxifene and breast cancer. Lorraine J CMAJ; 2001 Oct; 165(7):888. PubMed ID: 11599326 [No Abstract] [Full Text] [Related]
32. Conservation treatment intensified with an anti-estrogen agent and CAF chemotherapy for stage I and II breast cancer. Ogawa Y; Nishioka A; Inomata T; Ohnishi T; Kariya S; Terashima M; Yoshida S; Tohchika N; Tanaka Y; Kumon M Oncol Rep; 2000; 7(3):479-84. PubMed ID: 10767355 [TBL] [Abstract][Full Text] [Related]
33. Estrogen's dual nature? Studies highlight effects on breast cancer. Twombly R J Natl Cancer Inst; 2011 Jun; 103(12):920-1. PubMed ID: 21693756 [No Abstract] [Full Text] [Related]
34. Stabilization of hypomania following initiation of tamoxifen. Palmer JT; Payne JL Am J Psychiatry; 2008 May; 165(5):650-1. PubMed ID: 18450946 [No Abstract] [Full Text] [Related]
35. Anastrozole (Arimidex) vs. tamoxifen for treatment of early breast cancer. Med Lett Drugs Ther; 2003 Mar; 45(1152):22-3. PubMed ID: 12637893 [No Abstract] [Full Text] [Related]
36. LHRH agonists for adjuvant therapy of early breast cancer in premenopausal women. Sharma R; Hamilton A; Beith J Cochrane Database Syst Rev; 2008 Oct; (4):CD004562. PubMed ID: 18843661 [TBL] [Abstract][Full Text] [Related]
37. Tamoxifen and menopausal status: risks and benefits. Sasco AJ Lancet; 1996 Mar; 347(9003):761. PubMed ID: 8602018 [No Abstract] [Full Text] [Related]
38. Recent advances in endocrine therapy of breast cancer. Howell A; Dowsett M BMJ; 1997 Oct; 315(7112):863-6. PubMed ID: 9353509 [No Abstract] [Full Text] [Related]
39. Tamoxifen therapy--long-term results and complications. Moore MP; Kinne DW Adv Surg; 1996; 29():263-9. PubMed ID: 8720007 [No Abstract] [Full Text] [Related]
40. Prophylactic laparoscopic ovarian ablation for premenopausal breast cancer: medical and economic efficacy. Kwon AH; Yamada O; Uetsuji S; Matsui Y; Kamiyama Y Surg Laparosc Endosc; 1997 Jun; 7(3):223-7. PubMed ID: 9194283 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]